Spots Global Cancer Trial Database for hbv
Every month we try and update this database with for hbv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan | NCT02402699 | Advanced Melano... Hepatitis B Hepatitis C | 18 Years - | Bristol-Myers Squibb | ||
| Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) | NCT05781568 | HCC Cirrhosis, Live... NAFLD HBV HCV | Biomarker dosag... | - | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | |
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) | NCT05781568 | HCC Cirrhosis, Live... NAFLD HBV HCV | Biomarker dosag... | - | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | |
| Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC | NCT05195294 | Hepatocellular ... Liver Cancer, A... Liver Cell Carc... | LioCyx-M Lenvatinib | 18 Years - 75 Years | Lion TCR Pte. Ltd. | |
| Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma | NCT05738447 | Liver Cancer Hepatocellular ... | HBV mRNA vaccin... | 18 Years - 70 Years | West China Hospital | |
| Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | NCT01914744 | Non-Hodgkin Lym... Hepatitis B Rea... | Entecavir Lamivudine | 18 Years - 80 Years | Fudan University | |
| Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis | NCT00190385 | Compensated Cir... | Ultrasonographi... | 30 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | NCT01914744 | Non-Hodgkin Lym... Hepatitis B Rea... | Entecavir Lamivudine | 18 Years - 80 Years | Fudan University | |
| PROLIFICA - West African Treatment Cohort for Hepatitis B | NCT02129829 | Hepatitis B, Ch... Hepatocellular ... | Tenofovir disop... | 18 Years - | Imperial College London | |
| Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan | NCT02402699 | Advanced Melano... Hepatitis B Hepatitis C | 18 Years - | Bristol-Myers Squibb | ||
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy | NCT01970254 | Cancer Hepatitis B HBV Hepatitis B Inf... Malignant Neopl... | Hepatitis B Scr... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
| Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis | NCT05181332 | Cirrhosis Biliary Atresia Choledochal Cys... Primary Scleros... HBV HCV Autoimmune Hepa... | Prediction mode... | 0 Years - 18 Years | West China Hospital | |
| Marginal Zone Lymphoma Cohort in Korea | NCT02732236 | Lymphoma, B-Cel... | Rituximab | 20 Years - | Dong-A University Hospital | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy | NCT02081469 | Hepatitis B, Ch... Tumor | TDF | 18 Years - 70 Years | Chang Gung Memorial Hospital | |
| Marginal Zone Lymphoma Cohort in Korea | NCT02732236 | Lymphoma, B-Cel... | Rituximab | 20 Years - | Dong-A University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
